Understanding the catalytic functions of enzymes in metabolic pathways has led to the development of targeted treatments. These include enzyme replacement therapy, substrate reduction therapy, and gene therapy. By supplementing deficient enzymes or reducing the accumulation of toxic substrates, these treatments aim to restore normal metabolic function. For example, enzyme replacement therapy for Gaucher disease has significantly improved the quality of life for affected individuals.
